Integromics, a leader in IT solutions provision for life sciences in the areas of genomics and proteomics, has selected Dr Michael J McManus as President & CEO. Dr McManus will lead the company’s efforts to expand in the world market, with a particular focus on proteomics and on further developing Integromics’ activity in the US and Asian markets.